VIASYS NeuroCare Receives 510 Clearance for SONARA and SONARA/tek Digital Transcranial Doppler Systems
16th Nov 2006, 08:21 GMT
VIASYS Healthcare has received 510 clearance from the US FDA for SONARA and SONARA/tek digital Transcranial Doppler systems.
VIASYS NeuroCare Receives 510 Clearance for SONARA and SONARA/tek Digital Transcranial Doppler Systems related news:
- VIASYS NeuroCare Inc. Receives 510(K) Clearance for SONARA and SONARA/tek Digital Transcranial Doppler Systems — Nachrichten Ticker - www.finanzen.net
- Viasys Gets FDA Approval on Sonara — FDA News News from StratCenter.com
- Abit iDome DS 500 and SW 510 Digital Speakers — DarkVision Hardware Articles and Review from around the web
- North American Scientific Announces FDA Clearance of its ClearPath HDR Breast Brachytherapy System — FDA News News from StratCenter.com
- ReGen Biologics Announces Results of FDA Appeal — Government/ Industry Regulation News from StratCenter.com
- Viasys buys another sleep-therapy company — bizjournals.com Health Care:Biotechnology headlines
- Viasys Buys Maker of Sleep Apnea Treatment Equipment — RedOrbit News - Health
- Lenstec Receives FDA Clearance to Begin Clinical Trial of Softec HD IOL — ArriveNet : Health
- Irish Broadband receives 4 bids — Digital Media Europe - digital media news from across Europe
- Real-time, digital imaging diagnostics — Cameras and imaging systems latest news on Laboratorytalk
Latest news from FDA News News from StratCenter.com:
- North American Gets Cancer Treatment OK
- North American Scientific Announces FDA Clearance of its ClearPath HDR Breast Brachytherapy System
- Newly FDA Approved SmartLipo Laser Liposuction Available at the Intimate Rejuvenation and Innovative Surgery Center, Phoenix, AZ.
- ACT-AD Coalition Calls FDA's New Focus on Neurological Diseases a Positive 1st Step
- Ivax Diagnostics Delays Filing 3Q Report
- New Corporate Members and Leaders for C-Path's Predictive Safety Testing Consortium Announced
- Diagnosoft Receives FDA Approval for Cardiac MRI Quantitative Regional Function Software Based on the HARP Technology
- PAREXEL Consulting Expands Risk Mgmt Expertise, Appoints Former FDA Consumer Safety Officer Raymond T Oji as Senior Consultant
- Trubion Pharmaceuticals to Present at the Lazard Life Sciences Conference
- Critical Therapeutics Announces Efficacy Data for Controlled-Release Formulation of Zileuton Presented at ACAAI 2006 Annual Meeting